Hemant K. Rohera — biography and timeline

This is a biography assembled only from things a stranger can check: patent offices, a company register, a regulator, a medical index and a DOI registry. Every date below has a document behind it. What is not on the record is not on this page, and the last section says what that leaves out.

The short version

Independent inventor, based in Pune, Maharashtra, India. Three granted United States patents in three unrelated fields — vehicle power generation, hybrid energy storage and a bioelectronic medical device — all held personally rather than by any company. Three registered Indian companies that develop and commercialise those technologies. One review indexed in PubMed via PMC, and six technical notes deposited with registered DOIs.

The three name forms on the public record are Hemant K. Rohera, Hemant Karamchand Rohera and Hemant Rohera. They are one person, and the patent record itself is the reason there are three: why the record spells the name three ways.

The timeline, with the document behind each line

Dates are taken from the issuing authority in each case, not from a profile or a press item. Where a filing date and a grant date are both given, they are the United States application date and the United States issue date as they appear on the patent itself.

DateWhat happenedWhere it is recorded
2012–2019Director, Swatantra Power Private LimitedMinistry of Corporate Affairs
11 August 2015United States application filed — Hybrid power packUSPTO / Google Patents
17 September 2016United States application filed — Power generating system and method for a vehicleUSPTO / Google Patents
2018Rohera Industries (OPC) Private Limited incorporated, PuneMCA — CIN U73100PN2018OPC174240
2018Rohera Emerging Energies Private Limited incorporated, PuneMCA — CIN U29308PN2018PTC178170
31 December 2019US 10,523,019 B2 granted — Hybrid Power PackUSPTO
5 June 2020United States application filed — Medical therapeutic deviceUSPTO / Google Patents
2020Rohera Healthcare & Technology Private Limited incorporated, PuneMCA — CIN U33309PN2020PTC194671
14 September 2021US 11,117,476 B2 granted — OMNIA DriveUSPTO
25 January 2023ZA 2022/04073 B granted — eMedica, South AfricaCIPC
2023CDSCO Class A manufacturing licence MFG/MD/2023/000926 (Form MD-5)FDA Maharashtra
18 February 2025US 12,226,183 B2 granted — eMedicaUSPTO
September 2025Review published in Cureus, PMID 41116920PubMed / PMC
11 September 2026Six technical notes deposited on Zenodo with registered DOIsZenodo / DataCite

What the order of those dates actually says

The energy work came first. The Hybrid power pack application was filed in August 2015 and the vehicle power-generation application thirteen months later, in September 2016. The medical device application came nearly four years after that, in June 2020. The companies follow the same order: the two energy companies in 2018, the healthcare company in 2020.

That order matters because the obvious objection to a portfolio spanning three unrelated fields is that it looks unfocused. The honest answer is that it is one method applied three times rather than three separate interests, and the common thread is electrical: what a current does when it is delivered in a controlled way rather than an uncontrolled one. In a battery pack that means putting a capacitor where the transient goes. In a vehicle it means conditioning power at source. In a medical device it means a microampere-level waveform with recited parameter ranges. The argument is set out at length in the hybrid storage note and in the transmembrane-potential note, and either can be judged on its merits.

Three United States grants in three fields over ten years is a modest record by the standards of a corporate research department and an unusual one for an individual. Both of those things are true at once, and neither needs inflating.

The patents, held personally

The assignee field on all three granted United States patents reads Individual. The patents are not owned by any of the companies, and none of them sits on a corporate balance sheet. The consequences for chain of title and for licensing are set out in what "Individual" on the assignee line means and in the note on the three companies.

The portfolio runs to 2035, 2037 and 2041 on the United States grants — see remaining term across the portfolio. The full jurisdiction-by-jurisdiction position, with the lapsed and ceased entries named rather than quietly omitted, is on the patent register.

Which Hemant Rohera this is

The name is not rare, and several unrelated people share it or something close to it. The identifiers below resolve the question in one step, which is why they are on every page of this site rather than only on this one.

One collision is worth naming explicitly because it is a brand rather than a person. Emedica Ltd of the United Kingdom is a general-practice examination training company with no connection to the eMedica device or to any company here. They are unrelated organisations that share a name.

What this page does not claim

A biography is the easiest page on any site to inflate, so the limits are stated rather than left to inference.

Where to check every line of this